• 1
    Roizmann B., Desrosiers R.C., Fleckenstein B., Lopez C., Minson A.C., Studdert M.J. (1992) The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol 123: 42549.
  • 2
    Salahuddin S.Z., Ablashi D.V., Markham P.D., Josephs S.F., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong-Staal F., Kramarsky B., Gallo R.C. (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596601.
  • 3
    Aubin J.T., Collandre H., Candotti D., Ingrand D., Rouzioux C., Burgard M., Richard S., Huraux J.M., Agut H. (1991) Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol 29: 36772.
  • 4
    Campadelli-Fiume G., Guerrini S., Liu X., Foa-Tomasi L. (1993) Monoclonal antibodies to glycoprotein B differentiate human herpesvirus 6 into two clusters, variants A and B. J Gen Virol 74(Pt 10) 225762.
  • 5
    Wyatt L.S., Balachandran N., Frenkel N. (1990) Variations in the replication and antigenic properties of human herpesvirus 6 strains. J Infect Dis 162: 8527.
  • 6
    Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. (1988) Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 10657.
  • 7
    Okuno T., Takahashi K., Balachandra K., Shiraki K., Yamanishi K., Takahashi M., Baba K. (1989) Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 27: 6513.
  • 8
    Ahn K., Gruhler A., Galocha B., Jones T.R., Wiertz E.J., Ploegh H.L., Peterson P.A., Yang Y., Fruh K. (1997) The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 61321.
  • 9
    Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 4115.
  • 10
    Tomazin R., Van Schoot N.E., Goldsmith K., Jugovic P., Sempe P., Fruh K., Johnson D.C. (1998) Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol 72: 25603.
  • 11
    Wills M.R., Ashiru O., Reeves M.B., Okecha G., Trowsdale J., Tomasec P., Wilkinson G.W., Sinclair J., Sissons J.G. (2005) Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 175: 745765.
  • 12
    Jones T.R., Wiertz E.J., Sun L., Fish K.N., Nelson J.A., Ploegh H.L. (1996) Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 93: 11,32733.
  • 13
    Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., Ploegh H.L. (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 76979.
  • 14
    Ziegler H., Thale R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., Koszinowski U.H. (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6: 5766.
  • 15
    Coscoy L., Ganem D. (2000) Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA 97: 80516.
  • 16
    Hudson A.W., Howley P.M., Ploegh H.L. (2001) A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J Virol 75: 1234758.
  • 17
    Ishido S., Wang C., Lee B.S., Cohen G.B., Jung J.U. (2000) Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74: 53009.
  • 18
    Reusch U., Muranyi W., Lucin P., Burgert H.G., Hengel H., Koszinowski U.H. (1999) A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18: 108191.
  • 19
    Hirata Y., Kondo K., Yamanishi K. (2001) Human herpesvirus 6 downregulates major histocompatibility complex class I in dendritic cells. J Med Virol 65: 57683.
  • 20
    Glosson N.L., Hudson A.W. (2007) Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules. Virology 365: 12535.
  • 21
    Mori Y., Yagi H., Shimamoto T., Isegawa Y., Sunagawa T., Inagi R., Kondo K., Tano Y., Yamanishi K. (1998) Analysis of human herpesvirus 6 U3 gene, which is a positional homolog of human cytomegalovirus UL 24 gene. Virology 249: 12939.
  • 22
    Mori Y., Akkapaiboon P., Yang X., Yamanishi K. (2003) The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J Virol 77: 24528.
  • 23
    Mori Y., Koike M., Moriishi E., Kawabata A., Tang H., Oyaizu H., Uchiyama Y., Yamanishi K. (2008) Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 9: 172842.
  • 24
    Okuno T., Shao H., Asada H., Shiraki K., Takahashi M., Yamanishi K. (1992) Analysis of human herpesvirus 6 glycoproteins recognized by monoclonal antibody OHV1. J Gen Virol 73(Pt 2) 4437.
  • 25
    Tang H., Kawabata A., Takemoto M., Yamanishi K., Mori Y. (2008) Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology 378: 26571.
  • 26
    Kawabata A., Tang H.M., Huang H.L., Yamanishi K., Mori Y. (2009) Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts. Virology J 6: 127.
  • 27
    Yamada M., Mugnai G., Serada S., Yagi Y., Naka T., Sekiguchi K. (2013) Substrate-attached materials are enriched with tetraspanins and are analogous to the structures associated with rear-end retraction in migrating cells. Cell Adh Migr 7: 30414.
  • 28
    Akkapaiboon P., Mori Y., Sadaoka T., Yonemoto S., Yamanishi K. (2004) Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J Virol 78: 796983.
  • 29
    Mori Y., Akkapaiboon P., Yonemoto S., Koike M., Takemoto M., Sadaoka T., Sasamoto Y., Konishi S., Uchiyama Y., Yamanishi K. (2004) Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol 78: 460916.
  • 30
    Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., Geuze H.J. (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 116172.
  • 31
    Elboim M., Grodzovski I., Djian E., Wolf D.G., Mandelboim O. (2013) HSV-2 specifically down regulates HLA-C expression to render HSV-2-infected DCs susceptible to NK cell killing. PLoS Pathog 9: e1003226.
  • 32
    Kubota A., Kubota S., Farrell H.E., Davis-Poynter N., Takei F. (1999) Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell Immunol 191: 14551.
  • 33
    Ma G., Feineis S., Osterrieder N., Van De Walle G.R. (2012) Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I. J Virol 86: 355463.
  • 34
    Neumann L., Kraas W., Uebel S., Jung G., Tampe R. (1997) The active domain of the herpes simplex virus protein IC P47: a potent inhibitor of the transporter associated with antigen processing. J Mol Biol 272: 48492.
  • 35
    Raafat N., Sadowski-Cron C., Mengus C., Heberer M., Spagnoli G.C., Zajac P. (2012) Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope. Int J Cancer 131: E65969.
  • 36
    Said A., Azab W., Damiani A., Osterrieder N. (2012) Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other. J Virol 86: 805971.
  • 37
    Vasireddi M., Hilliard J. (2012) Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hosts. J Virol 86(12) 50311.